FDA/NIH diabetes public meeting
Executive Summary
FDA and National Institutes of Health will hold a joint public meeting May 13 and 14 to discuss the treatment of type 1 and type 2 diabetes mellitus. The FDA/NIH collaboration is part of Commissioner McClellan's strategic plan to develop a regulatory framework that would encourage the development of treatments in high-need areas, such as diabetes, cancer, obesity and lupus (1"The Pink Sheet" Feb. 10, 2003, p. 5)...